---
figid: PMC6995173__12964_2020_513_Fig7_HTML
figlink: pmc/articles/PMC6995173/figure/Fig7/
number: F7
caption: Model of NAMPT’s role in the proliferation of human CRC cells through the
  regulation of Wnt/β-catenin signaling. A high level of NAMPT (left panel) yields
  more NAD+ and induces downregulation of Axin and the nuclear translocation of β-catenin,
  thereby leading to the activation of Wnt/β-catenin signaling and the increased growth
  of CRC cells. However, when NAMPT is inhibited by genetic or pharmacological methods
  (right panel), the NAD+ level is reduced and Axin is upregulated. Then, β-catenin
  is degraded, and the Wnt/β-catenin pathway is suppressed, resulting in the inhibition
  of cancer cell proliferation
pmcid: PMC6995173
papertitle: Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal
  cancer growth and Wnt/β-catenin signaling via increasing Axin level.
reftext: Chenyang Ye, et al. Cell Commun Signal. 2020;18:16.
pmc_ranked_result_index: '4596'
pathway_score: 0.9746249
filename: 12964_2020_513_Fig7_HTML.jpg
figtitle: NAMPT’s role in the proliferation of human CRC cells through the regulation
  of Wnt/Beta-catenin signaling
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6995173__12964_2020_513_Fig7_HTML.html
  '@type': Dataset
  description: Model of NAMPT’s role in the proliferation of human CRC cells through
    the regulation of Wnt/β-catenin signaling. A high level of NAMPT (left panel)
    yields more NAD+ and induces downregulation of Axin and the nuclear translocation
    of β-catenin, thereby leading to the activation of Wnt/β-catenin signaling and
    the increased growth of CRC cells. However, when NAMPT is inhibited by genetic
    or pharmacological methods (right panel), the NAD+ level is reduced and Axin is
    upregulated. Then, β-catenin is degraded, and the Wnt/β-catenin pathway is suppressed,
    resulting in the inhibition of cancer cell proliferation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APC
  - CTNNB1
  - NAMPT
  - DVL3
  - DVL1
  - DVL2
  - AXIN1
  - AXIN2
  - CSNK1A1
  - GSK3A
  - GSK3B
  - NAD
  - NAMPT
  - FK866
genes:
- word: APC/B-catenin
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: APC/B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: APC/B-cateninMutationBackground
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: CK1
  symbol: CK1
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: CK1
  symbol: CK1
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
chemicals:
- word: NAD
  source: MESH
  identifier: D009243
- word: NAMPT
  source: MESH
  identifier: C085455
- word: FK866
  source: MESH
  identifier: C480543
diseases: []
figid_alias: PMC6995173__F7
redirect_from: /figures/PMC6995173__F7
figtype: Figure
---
